» Articles » PMID: 36011079

Effect of COVID-19 Lockdowns on Eye Emergency Department, Increasing Prevalence of Uveitis and Optic Neuritis in the COVID-19 Era

Overview
Specialty Health Services
Date 2022 Aug 26
PMID 36011079
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The COVID-19 pandemic led to the reorganization of the health care system. A decline in health- and life-saving procedures has been reported in various medical specialties. However, data on ophthalmic emergencies during lockdowns is limited. Methods: We conducted a retrospective, observational, case-control study of 2351 patients registered at the ophthalmic emergency department of a tertiary hospital in Poland during three national COVID-19 lockdowns (March/April 2020, November 2020, and March/April 2021) and corresponding months in 2019. Results: The total number of visits declined from a mean of 720/month in the non-COVID era to 304/month during COVID-19 lockdowns (p < 0.001). Ocular trauma incidence dropped significantly from 2019 (non-COVID months) to 2020/2021 (COVID group mean 201 vs. 97 patients monthly, respectively, p = 0.03). Of note, the percentage of foreign bodies removal was significantly higher during lockdowns than corresponding time in the non-COVID era. A downward trend for vitreous detachment and macular disorders cases was observed between COVID and non-COVID time. Uveitis and optic neuritis patients were seen more often during lockdowns (p < 0.001 and p = 0.0013, respectively). In contrast, the frequency of conjunctivitis and keratitis, potentially COVID-related problems, decreased significantly in COVID-19 time (mean 138 vs. 23 per month in non-COVID vs. COVID lockdowns, respectively, p < 0.001). Conclusions: The overall number of eye emergency visits declined during COVID-19 lockdowns. Conjunctivitis and keratitis rates dropped during the lockdowns. Interestingly, the frequency of immune-mediated ocular conditions (uveitis, optic neuritis) increased significantly which might be triggered by SARS-CoV2 infection.

Citing Articles

Bibliometric analysis of published works in ocular trauma: a growing focus on open globe injury.

Choudhry H, Kuklinski E, Fu A, Shukla P, Montani M, Eraky F Int Ophthalmol. 2025; 45(1):47.

PMID: 39881069 DOI: 10.1007/s10792-025-03417-5.


Causal effect of COVID-19 on optic nerve and visual pathway disorders: genetic evidence of lung-brain axis.

Cao C, Li Q, Cai D, Yue C, Zhao H Front Immunol. 2024; 15:1440262.

PMID: 39081310 PMC: 11286426. DOI: 10.3389/fimmu.2024.1440262.


A review of neuro-ophthalmic sequelae following COVID-19 infection and vaccination.

Shi J, Danesh-Meyer H Front Cell Infect Microbiol. 2024; 14:1345683.

PMID: 38299114 PMC: 10827868. DOI: 10.3389/fcimb.2024.1345683.


New onset or recurrence of uveitis following COVID-19 infection.

Feng H, Zhao M, Mo J, Cao X, Chen W, Wang H BMC Ophthalmol. 2024; 24(1):23.

PMID: 38233844 PMC: 10792851. DOI: 10.1186/s12886-024-03289-w.

References
1.
Benito-Pascual B, Gegundez J, Diaz-Valle D, Arriola-Villalobos P, Carreno E, Culebras E . Panuveitis and Optic Neuritis as a Possible Initial Presentation of the Novel Coronavirus Disease 2019 (COVID-19). Ocul Immunol Inflamm. 2020; 28(6):922-925. DOI: 10.1080/09273948.2020.1792512. View

2.
Poyser A, Deol S, Osman L, Kuht H, Sivagnanasithiyar T, Manrique R . Impact of COVID-19 pandemic and lockdown on eye emergencies. Eur J Ophthalmol. 2020; 31(6):2894-2900. PMC: 8606945. DOI: 10.1177/1120672120974944. View

3.
Smith E, Hill M, Anderson C, Sim M, Miles A, Reid D . Lived Experience of Emergency Health Care Utilization during the COVID-19 Pandemic: A Qualitative Study. Prehosp Disaster Med. 2021; 36(6):691-696. PMC: 8523975. DOI: 10.1017/S1049023X21001126. View

4.
Bhaskaran K, Sharma P . Distancing? But still I-care: Tele-ophthalmology during COVID-19 era. Indian J Ophthalmol. 2020; 68(7):1243-1244. PMC: 7574130. DOI: 10.4103/ijo.IJO_1875_20. View

5.
Labiris G, Panagiotopoulou E, Kozobolis V . A systematic review of teleophthalmological studies in Europe. Int J Ophthalmol. 2018; 11(2):314-325. PMC: 5824090. DOI: 10.18240/ijo.2018.02.22. View